Skip to main content
Caplight Logo









Spheryx, Inc.

Spheryx, Inc.

Private
New York City, New YorkFrontier & Industrial Techhttps://spheryx.com/

Last Round

Grant

Jul 7, 2017

Total Funding Raised

$2.96M

Company Overview

Spheryx, Inc. is an electronic equipment and instruments company that provides a suspension analysis technology designed for quality control and formulation development.

Sector

Frontier & Industrial Tech

Verticals

Biotech Equipment, Semiconductors, Sensors, Quality Management, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts, Hardware + Subscription

AI Layer

Application

Keywords

particle characterizationholographic video microscopysub-visible particle analysisSVP analysisrefractive index measurementprotein aggregationCMP slurry analysisanalytical instrumentsbiologic characterizationsemiconductor metrologyquality controlanalytical servicesformulation developmentmicrofluidicsCRO servicesTotal Holographic Characterization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spheryx, Inc. Comparables

Compare Spheryx, Inc. with similar companies based on industry and business-model similarity.

Spheryx, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PANGEA Unternehmerkapital
77%
Izon Science
76%
Spectris plc
73%

Spheryx, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 7, 2017
GrantSep 15, 2016
GrantJul 1, 2015
SeedMar 1, 2015

Spheryx, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 7, 2017

    Secured $2M from National Center for Advancing Translational Sciences and NIH RADx.

  • Sep 15, 2016

    $1.28M grant awarded by the National Science Foundation.

Spheryx, Inc. Filings

Explore SEC and related filing metadata, where available.

Spheryx, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Spheryx, Inc.'s valuation, stock price, and market status.

Is Spheryx, Inc. a public or private company?

Spheryx, Inc. is a private company.

What is the current stock price of Spheryx, Inc.?

Spheryx, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Spheryx, Inc. worth (valuation)?

Valuation information for Spheryx, Inc. is not publicly available.

Can I buy Spheryx, Inc. stock?

Spheryx, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Spheryx, Inc.'s last funding round?

Spheryx, Inc.'s most recent funding round was Grant on July 7, 2017.

Who are the main investors in Spheryx, Inc.?

Key investors in Spheryx, Inc. include NIH RADx, National Center for Advancing Translational Sciences, National Science Foundation.

Will Spheryx, Inc. IPO soon?

No public IPO plans have been announced for Spheryx, Inc..

How can I track Spheryx, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spheryx, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2014
Last FundingJul 7, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?